FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial
Shuying S. Li(Fred Hutch Cancer Center), Daniel E. Geraghty(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), David C. Montefiori(University of Sheffield), Raphaël Gottardo(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Heather A. Prentice(Kaiser Permanente), Michael D. Alpert(Harvard University Press), Paul T. Edlefsen(Fred Hutch Cancer Center), Daryl E. Morris(Fred Hutch Cancer Center), James Y. Dai(Fred Hutch Cancer Center), Georgia D. Tomaras(Duke University), Nelson L. Michael(Walter Reed Army Institute of Research), Abraham Pinter(Rutgers, The State University of New Jersey), Susan Zolla‐Pazner(New York University), Nicole Frahm(Fred Hutch Cancer Center), Guido Ferrari(Duke University), Holly Janes(Fred Hutch Cancer Center), Barton F. Haynes(Duke Medical Center), Punnee Pitisuttithum(Mahidol University), Gary J. Nabel(National Institutes of Health), Rasmi Thomas(Walter Reed Army Institute of Research), Jaranit Kaewkungwal(Mahidol University), Robert J. O’Connell(Walter Reed Army Institute of Research), Youyi Fong(Fred Hutch Cancer Center), Sorachai Nitayaphan(Royal Thai Army), Gustavo H. Kijak(Walter Reed Army Institute of Research), Merlin L. Robb(University of Maryland, Baltimore), M. Juliana McElrath(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Peter B. Gilbert(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Fusheng Li(Fred Hutch Cancer Center), Supachai Rerks‐Ngarm(Ministry of Public Health), Hua-Xin Liao(Duke University), Jérôme H. Kim(Walter Reed Army Institute of Research), Chul-Woo Pyo(Fred Hutch Cancer Center), David T. Evans(University of Wisconsin–Madison)
Cited by 109
Related Papers
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
|Cell|2020|4.5k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity
|Nature|2002|1.2k
Control of Viremia and Prevention of Clinical AIDS in Rhesus Monkeys by Cytokine-Augmented DNA Vaccination
|Science|2000|885
The immune response during acute HIV-1 infection: clues for vaccine development
|Nature reviews. Immunology|2009|846